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BACKGROUND: Diabetes is associated with gait deficits, future falls and disability, 
however it is unclear if associations remain after controlling for relevant confounders. This 
study investigated (i) the effects of type II diabetes on spatiotemporal gait parameters in 
community-dwelling older adults and (ii) if diabetes status was independently associated with 
future falls and disability, after controlling for gait and other confounders.  
METHODS: Baseline data were obtained from 2,608 community-dwelling adults (≥60 years) 
participating in The Irish Longitudinal Study on Ageing (TILDA). Diabetes was identified 
from self-reported doctors’ diagnosis, medications and glycated haemoglobin levels. Gait 
characteristics were obtained during single and dual task walking using a GAITRite® mat 
(n=2560). Incident falls and disability were collected over four years follow-up (n=2473). 
Associations between diabetes status and gait (cross-sectional) and falls and disability 
(longitudinal) were investigated using regression analysis, adjusting for medications, 
cardiovascular health, neuropsychological function and fall-related factors.   
RESULTS: Diabetes (prevalence = 9.1%) was cross-sectionally associated with shorter dual 
task step length after adjusting for covariates (β=-1.59, 95% CI: -3.10, -0.08, p<0.05). 
Diabetes was independently associated with increased risk of future IADL difficulty in those 
with no prior difficulty (IRR=1.51, 95% CI: 1.08 2.11, p<0.05) although dual task step length 
was an important confounder in all disability models. No independent associations between 






















CONCLUSIONS: Diabetes was independently associated with shorter dual task step length 
and increased risk of future IADL difficulty. Multidimensional interventions addressing poor 
health and function in those with diabetes may help reduce the risk of gait deficits and future 
disability.  























Diabetes is a leading cause of disability and death worldwide (1,2), with up to 95% of cases 
being type II diabetes (3). In Ireland, the prevalence of type II diabetes has been reported at 
9.5% in community-dwelling adults aged 50 years and over with 10% of these cases being 
undiagnosed (4). Risk factors for diabetes include increasing age, obesity and physical 
inactivity
 
(3). Diabetes is associated with an increased risk of cardiovascular disease but also 
complications such as retinopathy, neuropathy, nephropathy (5), cognitive dysfunction (6) 
and depression (7). Consequently, diabetes has been associated with reduced physical 
function, and an increased risk of falls and disability (8-10).  
Gait is a common but complex activity that requires integration of the neurological, 
musculoskeletal and cardiorespiratory systems. Gait impairments are associated with an 
increased risk for falls and immobility, which contribute to greater disability and 
institutionalization, increases in health care costs, and death (11-13). In a systematic review, 
Allet et al (14) reported gait abnormalities (e.g. reduced gait speed and stride length and 
increased cycle time) during normal walking in the diabetic population. However, most of the 
referenced studies were limited by small sample sizes, differing methodologies to assess gait, 
different exclusion criteria and the inclusion of both type I and type II diabetics with/without 
peripheral neuropathy. Two larger studies, which also did not distinguish between type I and 
II diabetes, reported that associations between diabetes and reduced gait speed (or pace) are 
attenuated when including cardiovascular health and medications (15) and cardiovascular risk 
factors (16) as covariates, suggesting that vascular comorbidity plays an important role. 
The dual task paradigm examines walking while carrying out a secondary attention-
demanding task. It is often used to examine the relationship between gait, cognition and falls
 
(17) and is considered a further challenge to gait stability over and above a single task test 






















performance and future fall risk in community-dwelling older adults (18), but studies of dual 
task gait in diabetic populations are limited. In one of few studies in this population, De 
Mettelinge et al (19) reported that older adults with diabetes have slower gait speed, shorter 
strides and higher stride length variability compared to controls during dual task walking. In 
addition, gait impairments in both single and dual task conditions were greater in those with 
impaired cognitive function, however these authors did not adjust for any other confounders.  
Understanding the independent associations between diabetes and gait during both single and 
dual task conditions would help to identify limitations in physical function and potential risk 
of future outcomes such as falls and disability. While many of the falls studies cited in the 
Yang et al (2016) systematic review adjusted for multiple confounders including objective 
measures of function (10), the disability studies cited in the Wong et al (2013) review 
adjusted for fewer and mostly self-reported confounders (9). It is important to determine if 
associations between diabetes status, falls and disability exist, independent of any gait 
deficits, cardiovascular, physical, mental and cognitive health and fall-related factors.  
Therefore, the aims of this study were to examine (i) spatiotemporal gait characteristics 
during single and dual task walking in community-dwelling older adults with and without 
diabetes (cross-sectional analysis) and (ii) the risk of falls and disability over four years 
follow-up associated with having diabetes at baseline (longitudinal analysis). Both analyses 
controlled for the effects of physical function, cardiovascular health, medications, 
neuropsychological function, and fall-related factors. We hypothesised that those with 
diabetes would display impaired gait characteristics and that any observed associations with 
future falls and disability would no longer be significant after controlling for gait deficits and 

























The Irish Longitudinal Study on Ageing (TILDA) is a large prospective cohort study of the 
social, economic, and health circumstances of community-dwelling adults resident in Ireland. 
Details of the sampling, study design and cohort have been published previously (20,21). 
Briefly, a stratified two-staged clustered procedure was used to sample from the An Post 
GeoDirectory, a listing of residential addresses in the Republic of Ireland. A total of 640 
clusters (or regions) were randomly sampled from 3,155 clusters nationwide with a 
probability proportional to size and stratified by geographic, and demographic factors. Forty 
addresses were randomly chosen within each cluster, and household residents aged ≥50 years 
and their spouses/partners (of any age) were eligible to participate. Ethical approval was 
obtained from the Faculty of Health Sciences Research Ethics Committee at Trinity College 
Dublin and written informed consent was obtained from all participants.   
Data collection consisted of a computer-assisted personal interview (CAPI), a self-
completion questionnaire (SCQ) and a comprehensive health assessment. The CAPI 
contained detailed questions on socio-demographic characteristics, wealth, health, healthcare 
utilisation, social support and participation, with data recorded by social interviewers in the 
participants’ own homes. After the interview, participants were provided with the SCQ which 
they completed in their own time and returned to the study coordinators. Finally, participants 
were invited to take part in a health assessment carried out in a dedicated centre by trained 
research nurses. This assessment included anthropometric, cognitive, cardiovascular, 
mobility, strength, bone, and vision tests and blood draws. A modified home-based 
























Baseline (Wave 1) data from 8,172 participants aged ≥50 years were obtained between 
January 2009 and July 2011 with follow-up interview data obtained at Wave 2 (February 
2012 - March 2013) or Wave 3 (March 2014 – October 2015). The inclusion criteria for the 
cross-sectional analysis included age ≥60 years, completion of a Wave 1 CAPI, attendance at 
a centre-based health assessment, provision of a blood sample for glycated haemoglobin 
(HbA1c) analysis and valid gait data (n=2,560); those who subsequently participated in either 
a Wave 2 or 3 CAPI were included in longitudinal analysis (n=2,473), see Figure 1. 
Diabetes 
Diabetes was identified by the presence of any of the following criteria: self-reported doctor 
diagnosis of diabetes (n=204), use of diabetes medications identified using the World Health 
Organisation Anatomic Therapeutic Classification codes ‘A10A’ for insulin and ‘A10B’ for 
oral anti-glycaemic medications (n=10), or HbA1c levels ≥ 48 mmol/mol as per the American 
Diabetes Association criteria (3) (n=20). Respondents were not explicitly asked what type of 
diabetes they had been diagnosed with, therefore, participants who reported being on insulin 
therapy at the time of the interview and received a doctor diagnosis of diabetes before the age 
of 40 were excluded due to the suspicion that they may have type I diabetes (n=2).  
Gait Assessment 
Spatiotemporal gait parameters were obtained using a computerized walkway with embedded 
pressure sensors (active area 4.88 m) (GAITRite®, CIR Systems Inc, New York, USA). 
Participants completed two trials in each of two conditions: i) walking at usual pace (single 
task) and ii) walking while simultaneously carrying out a cognitive task (reciting alternate 
letters of the alphabet, i.e. A-C-E, etc.) (dual task). Each trial consisted of one pass over the 






















mat to allow for acceleration and deceleration. They were allowed a practice trial in which 
they recited alternate letters in a seated position prior to the dual task walking condition.  
Gait analysis 
Gait speed, step length, double support phase, step width and step length variability were 
included in the analysis as they have previously been linked to outcomes such as falls. Gait 
data from the right and left legs were similar (r=0.93-0.99) and results were consistent across 
both limbs, therefore only data for the right leg are presented. Gait speed was calculated as 
distance travelled divided by ambulation time (cm/s). Step length was measured from the heel 
center of the right footfall to the heel center of the previous left footfall (cm). Total double 
support phase was calculated as the sum of the initial and terminal double support phases 
occurring during the stance phase of the right foot (%). Step width was defined as the lateral 
distance from the midline of the right heel to the line of progression of two consecutive left 
footfalls. Step length variability was reflected by coefficient of variation (CV) of step length. 
For each pass of the mat, mean data was calculated for each variable; these were then 
averaged across the two passes in each of the single and dual task conditions. For each gait 
variable, dual task decrement was calculated as (Single task gait variable – Dual task gait 
variable). Dual task cost (%) was calculated as ((Single task gait variable – Dual task gait 
variable) / Single task gait variable) x 100. The number of letters attempted and number of 
letters correct were also recorded for the first pass in the dual task condition. 
Covariates  
A number of covariates, that have known associations with diabetes, gait, falls and disability, 
were obtained during the CAPI and the health assessment. These covariates reflect 
cardiovascular health (5), cognitive function (6), depressive symptoms (7) and fall-related 






















secondary, or tertiary corresponding to ≤8, 9-13, and >13 years respectively) were obtained. 
Participants self-reported a doctor diagnosis of cardiovascular conditions including high 
blood pressure, high cholesterol, heart attack, heart failure, angina, stroke, transient ischaemic 
attack, heart murmur and arrhythmia with the number of conditions presented as 0, 1, 2 or ≥3 
conditions. The number of medications taken regularly was obtained and participants 
indicated their smoking status (coded as never smoked, past smoker, current smoker). 
Participants reported if they had fallen in the past year (coded as 0, 1 or ≥2 falls) and were 
asked if they were afraid of falling (coded as not afraid, somewhat afraid, very much afraid). 
Finally, participants rated their steadiness when walking as very steady, slightly steady, 
slightly unsteady or very unsteady (23); a binary variable was derived denoting steady (very 
steady) and unsteady (all other responses).  
A number of objective measurements were taken during the health assessment. Height and 
weight were measured using a 240 wall-mounted measuring rod and an electronic floor scales 
(SECA, Birmingham, UK) respectively. Mean grip strength from two trials on the dominant 
hand was obtained using a hydraulic hand dynamometer (Baseline®, Fabrication Enterprises, 
Inc., White Plains, NY). Global cognition was assessed using the Montreal Cognitive 
Assessment (MoCA) (24). Colour Trail Task 2 (25) time was used to assess executive 
function and a computer-based choice reaction time test was used to assess processing speed. 
Depressive symptoms were measured using the 8-item Centre for Epidemiologic Studies 
Depression (CES-D) Scale (26). 
Longitudinal outcome variables 
All longitudinal outcomes were dichotomous variables, derived from data available at Wave 
2, Wave 3 or both waves. Outcomes were recurrent falls (two or more falls occurring in the 
past year or since the last interview), injurious falls (injured seriously enough to require 






















difficulty in performing at least one instrumental activity of daily living (IADL) because of a 
physical or mental health problem. ADLs included dressing, walking across a room, bathing 
or showering, eating, getting in or out of bed, and using the toilet (27) whereas IADLs 
included preparing a hot meal, doing household chores, shopping for groceries, making 
telephone calls, taking medications, and managing money (28). Routine performance of these 
activities was not taken into account (e.g. if the participant typically did the food preparation 
or shopping in the household). 
Statistical analysis 
Baseline characteristics of those with and without diabetes were summarised using means and 
standard deviations for continuous variables and frequency counts and proportions for 
categorical values. Gait characteristics in both single and dual task conditions are presented 
where data were available. Marginal distributions of gait variables were assessed using 
histograms and Q-Q plots. All variables were normally distributed except for step length 
variability which was positively skewed.  
Separate linear (for normally distributed variables) and quantile (for skewed variables) 
regression models were used to examine the association between diabetes status (independent 
variable) and each gait variable, namely gait speed, step length, double support phase, step 
width and step length variability in both single and dual task walking conditions, dual task 
decrement measures, dual task cost measures, number of letters attempted and recited 
correctly (dependent variables). Regression analysis was deemed the most suitable approach 
as unequal sample sizes in the diabetes and non-diabetes groups can affect the homogeneity 
of variance assumption in ANOVA. For each dependent variable, Model 1 was unadjusted 
while Model 2 adjusted for age, sex, education, height and weight. Each covariate was then 
added individually to the models with the change in beta coefficients reflecting the 






















greater extent compared to other variables was deemed to be an important confounder in the 
observed relationship. Model 3 was adjusted for age, sex, education, height, weight, number 
of medications, number of cardiovascular conditions, MoCA, choice reaction time, Colour 
Trail Test 2, depressive symptoms, grip strength, smoking status, falls in the past year, fear of 
falling and unsteadiness during walking.  
For longitudinal analysis, we used generalised linear models with poisson regression to 
examine associations between diabetes status and falls (recurrent, injurious) and difficulty in 
ADLs and IADLs occurring over 4 years follow-up. Model 1 was unadjusted while Model 2 
adjusted for age, sex, education, height, weight and time between baseline health assessment 
and follow-up interviews. Once again, the covariates listed above were added individually 
with the confounding effect of each variable reflected by the change in the incidence rate 
ratio (IRR). A variable that reduced the IRR to a much greater extent compared to other 
variables was deemed to be an important confounder in the observed relationship. Model 3 
was adjusted for all covariates. Complete case analysis was used for multivariate analyses 
with all missing data treated as missing at random. We repeated this analysis for each 
outcome, excluding those with a history of falls in the past year (for the falls models), ADL 
difficulty at baseline (for the ADL difficulty model) and IADL difficulty at baseline (for the 
IADL difficulty model) respectively.  
All regression models included inverse probability weights created by comparing age, sex, 
education, marital status and geography of participants to their distribution in the Irish Census 
2011. These weights were modified further to reflect the non-uniform probability for 
participant self-selection into the centre-based health assessment. Significance was 
considered at the 5% level. All analyses were carried out in Stata v14 (StataCorp, College 
























The final sample for cross-sectional analysis was 2,560 participants for whom Wave 1 
diabetes status and gait data were available (Figure 1). 9.1% (n=234) of participants were 
identified as having diabetes.  
Adults with diabetes were more likely to be older, male, heavier in weight, a past smoker, 
with primary level education (≤8 years), a higher number of cardiovascular conditions and 
medications, to self-report a history of falls, fear of falling, difficulty with ADLs and IADLs 
and unsteadiness during walking and to demonstrate poorer cognitive performance compared 
to those without diabetes (eTable1). Similarly, the diabetes group displayed poorer gait 
characteristics (i.e. slower gait speed, shorter step length, increased time spent in double 
support, wider steps and increased step length variability) compared to the non-diabetes 
group in both single and dual task walking conditions (Table 1).  
Results of the regression analyses for single task gait are presented in Table 2. The 
unadjusted differences in gait characteristics between diabetes and non-diabetes groups are 
shown in Model 1. The diabetes group had slower gait speed and shorter step length after 
adjusting for basic socio-demographics (Model 2) but neither of these associations persisted 
after adjusting for all covariates (Model 3).  
Results of the regression analyses for dual task gait are presented in eTable2. The diabetes 
group displayed slower gait speed, shorter step length and increased double support phase 
and step width after adjusting for age, sex, education, height and weight (Model 2). Only the 
association between diabetes and shorter dual task step length remained after adjusting for 






















Diabetes status was not associated with any measures of dual task cost or dual task 
decrement, or number of letters attempted or recited correctly during the dual task condition 
(data not shown).  
Longitudinal analysis 
Follow-up data were available for 2,473 participants (median follow-up: 4.3 years; range: 
1.5-5.8 years) including 228 participants with diabetes at baseline. The incidence of falls, 
ADL difficulty and IADL difficulty after four years follow-up, stratified by diabetes status is 
provided in Table 3. The diabetes group reported higher incidence of recurrent falls, ADL 
and IADL difficulty compared to those without diabetes while injurious falls were similar in 
both groups.  
Table 4 shows that diabetes was associated with an increased risk of recurrent falls, ADL 
difficulty and IADL difficulty in Model 1 (unadjusted). Diabetes was associated with an 
increased risk of ADL difficulty (IRR=1.40, 95% CI: 1.09, 1.81, p<0.01) and IADL difficulty 
(IRR=1.60, 95% CI: 1.26, 2.03, p<0.001) when adjusting for socio-demographic factors in 
Model 2, however none of these associations remained significant when adjusting for all 
covariates in Model 3.  
When the analysis was repeated for participants with no history of disability at baseline, 
diabetes was associat d with an increased risk of incident ADL difficulty (IRR=1.47, 95% 
CI: 1.09, 1.99, p<0.05) and IADL difficulty (IRR=1.78, 95% CI: 1.35, 2.36, p<0.001; 
eTable3) when adjusting for socio-demographic variables (Model 2). The observed 
association between diabetes and IADL difficulty remained significant after controlling for 
all covariates in Model 3 (IRR=1.51, 95% CI: 1.08, 2.11, p<0.05), although this association 























There were no associations between diabetes and injurious falls in those with or without a 
history of falls in the year prior to baseline (data not shown). 
 
Discussion 
In this study, diabetes was independently associated with shorter dual task step length in 
cross-sectional analysis; and an increased risk of IADL difficulty after four years follow-up 
in those with no prior history of difficulty, when controlling for gait and physical function, 
cardiovascular health, medications, neuropsychological function, and fall-related factors. 
Number of medications was the most important confounding factor in the cross-sectional 
models suggesting that existing co-morbidities and corresponding health status have a 
considerable impact on gait. Dual task step length was an important confounding factor in the 
longitudinal models, reflecting the importance of both mobility and cognitive function in 
carrying out activities of daily living.  
To our knowledge, this is the first population-based study to examine both single and dual 
task gait performance in diabetic and non-diabetic older adults. Our single task gait findings 
are in contrast to Maksimovic et al (16) who reported that diabetes was associated with a 
reduction in the pace factor (predominantly made up of gait speed and step length) during 
single task walking after adjusting for socio-demographics, height, weight, cardiovascular 
risk factors and medication use. Several other papers have also reported gait deficits in 
diabetic cohorts, however as these studies used mostly unadjusted or partially adjusted 
analyses (e.g. age, sex, BMI and individual indicators of health, cognition, etc), they more 
closely reflect our findings from Models 1 and 2 (16,29,30). The independent association 
between diabetes and shorter dual task step length observed in our study suggests that 






















conditions, which is supported by research reporting cognitive dysfunction in those with 
diabetes (6).  
We also found that shorter dual task step length was an important confounding factor in all of 
the disability models, which likely reflects the mobility and cognitive requirements to 
perform ADLs, and IADLs in particular. Interestingly, dual task step length had a much 
stronger confounding effect than individual cognitive function variables (see IRRs in Table 4, 
Model 2 + individual variables) suggesting that this measure may represent an early indicator 
of difficulty in tasks requiring executive function and highlighting the potential it has in 
identifying individuals with future disability.  
The association between diabetes and future IADL difficulty in those with no baseline 
difficulty remained significant even after controlling for dual task step length. This 
independent association is consistent with findings of studies included in Wong et al’s 
systematic review (9), highlighting the need to address these functional limitations in older 
adults with diabetes. In contrast to previous studies (31,32), we found no independent 
association between diabetes and incident ADL difficulty although we did adjust for 
objective indicators of cardiovascular function and neuropsychological function, which these 
previous studies did not do.  
The underlying mechanism linking diabetes, dual task gait deficits and future IADL difficulty 
may be related to vascular risk factors and pathologies. Recently, Liu et al (33) presented 
evidence of a causal association between type II diabetes and cerebral small vessel disease, 
indicators of which, include white matter hyperintensities (WMH) and reduced white 
matter integrity. Ghanavati et al (34) reported that greater volumes of deep WMH and 
reduced white matter integrity in the cingulum (an area which is important for attention) have 






















associated with lower cerebral CO2 vasoreactivity in type II diabetes (35). This may be due 
to endothelial dysfunction, as a result of hyperglycemia and elevated proinflammatory 
cytokine levels (36) and/or increased blood-brain permeability (37). Previous studies in 
those with type II diabetes have shown that lower global cerebral vasoreactivity at baseline 
is associated with a greater decrease in single and dual task gait speed and dual task cost 
(38) and decline in IADL scores (36) at two years follow-up. Chung et al (38) also reported 
a more pronounced decline in cerebral vasoreactivity in those with a longer duration of 
diabetes. It is known that type II diabetes may go undiagnosed for many years, with micro- 
and macro-vascular complications often already present at the time of diagnosis (3). The 
length of time lived with the condition increases the risk of diabetic complications, and these 
can directly (e.g. through peripheral arterial disease, peripheral neuropathy) or indirectly (e.g. 
through ulcers, muscle weakness) affect an individual’s walking patterns and/or increase the 
risk of falls and disability. This highlights the importance of managing vascular risk factors 
such as hypertension in diabetes to reduce the risk and severity of cerebral small vessel 
disease and possible effects on gait, falls and disability.  
Previous research has shown that polypharmacy is more prevalent in those with diabetes 
compared to those without (39). In the present study, number of medications was one of the 
strongest confounders of the associations between diabetes and all outcomes. For example, 
when number of medications was added to the cross-sectional model for single task gait 
speed, it reduced β by 86% while adding each of the other confounders reduced β by ≤23% 
(Table 2, Model 2). A higher number of medications likely reflects greater co-morbidity, the 
well-established deficits in physical (8,40) and cognitive function (40,41), and higher 
prevalence of depression (8), sarcopenia and frailty (42) associated with diabetes. Taking 
multiple medications leads to an increased risk of side-effects and drug-drug interactions, 






















may also be associated with an increased risk of falls, cognitive changes and heart disease 
(43). While we did not observe an association between diabetes and falls after adjusting for 
socio-demographics (see Table 4, Model 2), previous research has reported that medications 
are an important confounder of this relationship (44,45) along with reduced physical and 
cognitive function.  
The strengths of this study include the large, population based sample of community-
dwelling adults, the use of HbA1c to capture undiagnosed diabetes, the comprehensive gait 
assessment completed by the majority of participants, availability of a range of demographic 
and health covariates and follow-up data available over four years. The study is limited to 
those participants who attended a centre-based health assessment who tended to be higher 
functioning compared to those who selected a home-based assessment (22). The question 
used to ascertain a diabetes diagnosis in the TILDA interview does not distinguish between 
different types of diabetes. While we excluded those who were likely to have type I diabetes 
based on medication usage and age at diagnosis, we were unable to account for other types of 
the disease, including gestational diabetes or latent autoimmune diabetes which may be 
present in this population. We did not control for the duration of diabetes or the presence of 
diabetes-related complications such as leg ulcers, protein in the urine, neuropathy, 
retinopathy and nephropathy as this information was only available for participants reporting 
a doctors’ diagnosis of diabetes and the prevalence of reported complications in this group 
was low. In addition, falls were self-reported which may be subject to recall bias although 
using recurrent falls (more than one fall in a specified period) and injurious falls (serious 
enough to require medical treatment) may alleviate this problem to some extent.  
In conclusion, community-dwelling adults with type II diabetes had shorter dual task step 
length and an increased risk of IADL difficulty over four years compared to those without 






















and fall-related factors. Number of medications is an important confounder in all observed 
associations, indicating that the presence of co-morbidities and associated deficits in health 
and function accounts for much of the gait deficits. Shorter dual task step length is also an 
important confounder in the association between diabetes and disability highlighting the role 
of mobility and cognitive function. Recent intervention studies have shown that diet (46) and 
exercise (47) interventions have the potential to improve lower extremity function, including 
gait parameters, in older adults with type II diabetes. It is unclear from existing reviews if 
polypharmacy interventions have led to clinically important outcomes, however some 
evidence does suggest more appropriate prescribing, highlighting the role that targeted 
review, appropriate monitoring and personalised medicine can play in reducing the risk of 
adverse outcomes associated with polypharmacy (48). Multidimensional interventions aimed 
at addressing poorer health and function in those with diabetes may therefore help to reduce 
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Figure 1. Flowchart of study participants 
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Table 1. Gait characteristics during the single and dual task walking conditions by diabetes status 
 Single task walking Dual task walking 












Gait Speed (cm/s) 130.79 (20.31) 121.21 (21.33) 106.15 (25.48) 99.05 (22.43) 
Step length (cm) 68.75 (9.01) 65.72 (9.58) 64.89 (10.81) 61.91 (10.63) 
Double support phase (%) 25.70 (4.43) 27.71 (5.41) 27.20 (5.40) 29.30 (5.86) 
Step width (cm) 8.62 (2.95) 9.90 (3.20) 8.96 (3.50) 10.75 (3.92) 
























Table 2. Associations between diabetes status and gait characteristics during single task walking (right leg)  
 Gait speed 
β (95% CI) 
Step length 
β (95% CI) 
Double support phase 
β (95% CI) 
Step width 
β (95% CI) 
Step length variability  
β (95% CI) 
Model 1
a
 -9.46 (-13.02,-5.90)*** -3.21 (-4.82, -1.61)*** 2.13 (1.23,3.02)*** 1.41 (0.85,1.96)*** 0.55 (0.22,0.88)** 
Model 2
b
 -5.41 (-8.76,-2.06)** -2.54 (-3.90,-1.17)*** 0.71 (-0.13,1.56) 0.46 (-0.05,0.97) 0.35 (0.00,0.71) 
+ medications -0.77 (-3.97,2.43) -1.07 (-2.40,0.26) -0.02 (-0.90,0.85) 0.23 (-0.30,0.76) 0.32 (0.01,0.64)* 
+ CV conditions -4.57 (-7.87,-1.29)** -2.28 (-3.65,-0.92)** 0.57 (-0.28,1.42) 0.44 (-0.09,0.96) 0.38 (0.04,0.72)* 
+ MoCA -5.31 (-8.69,-1.94)** -2.47 (-3.83,-1.10)*** 0.70 (-0.15,1.55) 0.45 (-0.07,0.96) 0.38 (0.05,0.70)* 
+ CRT -4.23 (-7.43,-1.03)* -2.12 (-3.46,-0.77)** 0.39 (-0.47,1.26) 0.52 (0.04,0.99)* 0.43 (0.06,0.79)* 
+ CTT2 -5.38 (-8.53,-2.23)** -2.49 (-3.76,-1.22)*** 0.59 (-0.27,1.46) 0.41 (0.12,0.93) 0.35 (0.02,0.68)* 
+ CES-D -4.72 (-8.01,-1.43)** -2.27 (-3.63,-0.91)** 0.62 (-0.22,1.48) 0.43 (-0.09,0.95) 0.40 (0.05,0.75)* 
+ grip strength -4.80 (-8.10,-1.50)** -2.29 (-3.60,-0.97)** 0.57 (-0.24,1.38) 0.43 (-0.08,0.95) 0.36 (0.02,0.70)* 
+ smoking status -5.01 (-8.30,-1.73)** -2.41 (-3.77,-1.05)** 0.66 (-0.19,1.51) 0.45 (-0.07,0.97) 0.37 (-0.02,0.76) 
+ previous falls -5.30 (-8.66,-1.95)** -2.50 (-3.87,-1.13)*** 0.72 (-0.12,1.56) 0.47 (-0.05,0.98) 0.46 (0.13,0.79)** 






















+ unsteadiness -4.18 (-7.20, -1.15)** -2.06 (-3.29,-0.83)** 0.53 (-0.29,1.35) 0.37 (-0.15,0.89) 0.31 (0.04,0.59) 
Model 3
c
 -0.79 (-3.68, 2.11) -1.07 (-2.33,0.19) -0.18 (-1.05,0.70) 0.30 (-0.22,0.82) 0.23 (-0.16,0.61) 
N 2420-2560 2420-2560 2420-2560 2420-2560 2417-2557 
      
Note. No Diabetes=Reference Category. Linear regression models used for gait speed, step length, double support phase and step width; 
quantile regression models used for step length variability; all analyses were weighted. CES-D, Centre for Epidemiological Studies Depression 
Scale; CRT, choice reaction time; CTT2, Colour Trails Test 2; CV, cardiovascular; MoCA, Montreal Cognitive Assessment. 
a
Model 1 unadjusted. 
b
Model 2 adjusted for age, sex, education, height, weight + the individual variables indicated. 
c
Model 3 adjusted for age, sex, education, height, weight, number of medications, number of CV conditions, MoCA, CRT, CTT2, depressive 
symptoms (CES-D), grip strength, smoking status, previous falls, fear of falling, unsteadiness during walking. 






















Table 3: Incidence of recurrent and injurious falls, ADL and IADL difficulty occurring after 
4 years follow-up by diabetes status.  




Recurrent falls 422 (18.8) 59 (25.9) 
Injurious falls 429 (19.1) 44 (19.3) 
ADL difficulty 388 (17.3) 63 (27.6) 
IADL difficulty 377 (16.8) 64 (28.1) 
   
In those who did not report these outcomes at baseline 
Recurrent falls 
a
 257 (14.6) 30 (19.2) 
Injurious falls 
a
 280 (15.9) 21 (13.5) 
ADL difficulty 
b
 311 (15.1) 45 (23.0) 
IADL difficulty 
c
 315 (14.8) 50 (24.1) 
Note. ADL, activities of daily living; IADL, instrumental activities of daily living.  
a



































Table 4. Associations of diabetes status with recurrent falls, difficulty in ADLs and IADLs at four year follow-up 
  Recurrent falls ADL difficulty IADL difficulty 
 IRR (95% CI) IRR (95% CI) IRR (95% CI) 
Model 1
a
 1.33 (1.01,1.76)* 1.43 (1.11,1.85)** 1.55 (1.20,1.99)***  
Model 2
b
 1.25 (0.95,1.65) 1.40 (1.09,1.81)** 1.60 (1.26,2.03)*** 
+ medications 0.99 (0.73,1.34) 1.16 (0.88,1.53) 1.31 (1.01,1.69)* 
+ CV conditions 1.17 (0.89,1.54) 1.36 (1.06,1.75)* 1.56 (1.23,1.98)*** 
+ MoCA 1.25 (0.95,1.65) 1.37 (1.05,1.78)* 1.55 (1.21,1.98)*** 






















+ colour trails 2  1.29 (0.97,1.71) 1.42 (1.08,1.87)* 1.61 (1.23,2.10)** 
+ depressive symptoms 1.20 (0.92,1.57) 1.35 (1.05,1.75)* 1.57 (1.23,2.00)*** 
+ grip strength 1.23 (0.94,1.62) 1.39 (1.07,1.81)* 1.60 (1.25,2.05)*** 
+ smoking status 1.25 (0.95,1.65) 1.37 (1.06,1.76)* 1.59 (1.25,2.02)*** 
+ previous falls 1.16 (0.88,1.53) 1.36 (1.05,1.76)* 1.58 (1.24,2.01)*** 
+ fear of falling 1.24 (0.96,1.61) 1.41 (1.09,1.82)** 1.63 (1.28,2.07)*** 
+ unsteadiness 1.20 (0.91,1.58) 1.32 (1.01,1.71)* 1.48 (1.16,1.90)** 
+ ADL difficulty - 1.31 (1.00,1.70)* - 
+ IADL difficulty - - 1.41 (1.09,1.82)** 
+ step length (dual task) 1.17 (0.88,1.57) 1.24 (0.92,1.65) 0.99 (0.68,1.42) 
Model 3
c
 1.05 (0.78,1.41) 1.21 (0.88,1.67) 1.03 (0.71,1.50) 
N 2293-2473 2293-2473 2293-2473 
Note. No Diabetes=Reference Category. Generalised linear models with poisson regression used; all analyses were weighted. ADL, activities of 
daily living; CV, cardiovascular; IADL, instrumental activities of daily living; IRR, incidence rate ratio; MoCA, Montreal Cognitive 
Assessment. 
a























Model 2 adjusted for age, sex, education, height, weight, time between baseline health assessment and follow-up interview + the individual 
variables indicated. 
c
Model 3 adjusted for age, sex, education, height, weight, time between baseline health assessment and follow-up interview, number of 
medications, number of CV conditions, MoCA, choice reaction time, Colour Trail Test 2, depressive symptoms, grip strength, smoking status, 
falls in the year prior to baseline, fear of falling, unsteadiness, ADL difficulty at baseline (ADL difficulty model only), IADL difficulty at baseline 
(IADL model only), step length (dual task). 
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